At the Albert Einstein College of Medicine and Montefiore Health System, Bronx, New York, Anna Flattau, MD, MS, MSc, is Associate Professor and Vice Chair, Department of Family and Social Medicine; Giacomo Vinces, DO, is Assistant Professor, Department of Family and Social Medicine; Shuo You, MD, is Research Coordinator, Division of Hematology, Department of Medicine; Andrew S. Crouch, BA, is Research Coordinator, Division of Hematology, Department of Medicine; and Caterina P. Minniti, MD, is Professor, Division of Hematology, Department of Medicine. Acknowledgment: This work was partially supported by a grant from the FDA (R01FD005729). The authors have disclosed no other financial relationships related to this article. Submitted October 29, 2020; accepted in revised form November 23, 2020.
Adv Skin Wound Care. 2021 Oct 1;34(10):539-541. doi: 10.1097/01.ASW.0000790476.13111.5f.
Leg ulcers affect 15% of people with sickle cell disease. However, wound centers typically treat few people with this condition, which makes it difficult to concentrate clinical expertise or support the scientific study of this orphan disease. This article describes an initiative to increase engagement in care through a partnership between wound healing and hematology leadership that led to colocating wound services within a sickle cell clinic.
Via a retrospective chart review, the authors collected records of all adult patients with sickle cell disease who received wound care in the last decade, including 7 years of wound center data and 3 years of data from the colocated services. Patient and visit characteristics were analyzed using descriptive analytics.
The general wound center had previously treated 35 patients with sickle cell ulcers over 7 years. In contrast, colocated services engaged 56 patients within 3 years, including 20 who transferred care and 36 new patients. The majority of patients at the colocated site were women, unlike at the wound center (58% vs 47%, P = .07). Results indicated that 36% of patients healed initial wounds, and 45% had new wound occurrences.
Colocation successfully increases the number of patients with sickle cell ulcers who will engage in wound care at a single site, laying the foundation for clinical studies to improve the evidence base for this difficult-to-treat condition.
镰状细胞病患者中有 15%会出现腿部溃疡。然而，伤口中心通常很少治疗这种疾病患者，这使得集中临床专业知识或支持对这种孤儿病的科学研究变得困难。本文描述了一项通过伤口愈合和血液学领导之间的合作来增加对护理的参与度的举措，该举措导致伤口服务与镰状细胞诊所合作。
通过回顾性图表审查，作者收集了过去十年中所有接受伤口护理的镰状细胞病成年患者的记录，包括 7 年的伤口中心数据和 3 年的合作服务数据。使用描述性分析方法分析患者和就诊特征。
一般的伤口中心之前在 7 年内治疗了 35 例镰状细胞溃疡患者。相比之下，合作服务在 3 年内为 56 名患者提供了服务，其中包括 20 名转来的患者和 36 名新患者。与伤口中心（58%比 47%，P =.07）不同，合作服务点的大多数患者为女性。结果表明，36%的患者初始伤口愈合，45%的患者出现新伤口。
合作成功地增加了在单一地点接受伤口护理的镰状细胞溃疡患者数量，为改善这种难以治疗的疾病的证据基础的临床研究奠定了基础。
